Hutton J - Search Results

1

Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy.

Brown RE, Henderson RA, Koster D, Hutton J, Simoons ML. Brown RE, et al. Among authors: hutton j. Eur Heart J. 2002 Jan;23(1):50-8. doi: 10.1053/euhj.2001.2711. Eur Heart J. 2002. PMID: 11741362 Clinical Trial.

2

Cost effectiveness of treatment options in advanced breast cancer in the UK.

Brown RE, Hutton J, Burrell A. Brown RE, et al. Among authors: hutton j. Pharmacoeconomics. 2001;19(11):1091-102. doi: 10.2165/00019053-200119110-00003. Pharmacoeconomics. 2001. PMID: 11735676 Review.

3

Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients.

Brown RE, Hutton J. Brown RE, et al. Among authors: hutton j. Anticancer Drugs. 1998 Nov;9(10):899-907. doi: 10.1097/00001813-199811000-00009. Anticancer Drugs. 1998. PMID: 9890701

4

A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer.

Hutton J, Brown R, Borowitz M, Abrams K, Rothman M, Shakespeare A. Hutton J, et al. Pharmacoeconomics. 1996;9 Suppl 2:8-22. doi: 10.2165/00019053-199600092-00004. Pharmacoeconomics. 1996. PMID: 10163967 Review.

5

Use of economic evaluation in decision making: what needs to change?

Hutton J, Brown RE. Hutton J, et al. Value Health. 2002 Mar-Apr;5(2):65-6. doi: 10.1046/j.1524-4733.2002.52115.x. Value Health. 2002. PMID: 11918820 Free article. No abstract available.

6

Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole.

Chambers M, Hutton J, Gladman J. Chambers M, et al. Among authors: hutton j. Pharmacoeconomics. 1999 Nov;16(5 Pt 2):577-93. doi: 10.2165/00019053-199916050-00013. Pharmacoeconomics. 1999. PMID: 10662482 Clinical Trial.

7

Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.

Davies A, Ridley S, Hutton J, Chinn C, Barber B, Angus DC. Davies A, et al. Among authors: hutton j. Anaesthesia. 2005 Feb;60(2):155-62. doi: 10.1111/j.1365-2044.2004.04068.x. Anaesthesia. 2005. PMID: 15644013 Free article.

8

Cost-effectiveness analysis of interferon beta in multiple sclerosis: a Markov process analysis.

Nuijten MJ, Hutton J. Nuijten MJ, et al. Among authors: hutton j. Value Health. 2002 Jan-Feb;5(1):44-54. doi: 10.1046/j.1524-4733.2002.51052.x. Value Health. 2002. PMID: 11873383 Free article.

9

Development of a decision-analytic model of stroke care in the United States and Europe.

Chambers MG, Koch P, Hutton J. Chambers MG, et al. Among authors: hutton j. Value Health. 2002 Mar-Apr;5(2):82-97. doi: 10.1046/j.1524-4733.2002.52011.x. Value Health. 2002. PMID: 11918824 Free article.

10

Treatment pathways, resource use and costs in the management of small cell lung cancer.

Oliver E, Killen J, Kiebert G, Hutton J, Hall R, Higgins B, Bourke S, Paschen B. Oliver E, et al. Among authors: hutton j. Thorax. 2001 Oct;56(10):785-90. doi: 10.1136/thorax.56.10.785. Thorax. 2001. PMID: 11562518 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

977 results

Search Page

Filters